LENZ Therapeutics (LENZ) Cash from Operations (2020 - 2026)

LENZ Therapeutics (LENZ) has 7 years of Cash from Operations data on file, last reported at 33582000.0 in Q1 2026.

• On a quarterly basis, Cash from Operations fell 109.25% year-over-year to 33582000.0 in Q1 2026; TTM through Mar 2026 was 86703000.0, a 68.35% decrease from a year earlier, with the FY2025 full-year figure at 69170000.0, down 16.47% from the prior year.
• Cash from Operations for Q1 2026 stood at 33582000.0, down from 33025000.0 in the prior quarter.
• Over the last five years, Cash from Operations for LENZ reached as high as 8588000.0 in Q3 2025 and fell as low as 33582000.0 in Q1 2026.
• Historically, Cash from Operations has averaged 18264882.35 across 5 years, with a median of 16049000.0 in 2025.
• Across the five-year window, Cash from Operations soared 56.71% in 2024 and slumped 263.79% in 2025, its largest moves.
• Year by year, Cash from Operations stood at 22429000.0 in 2022, then gained by 6.5% to 20970000.0 in 2023, then surged by 56.71% to 9078000.0 in 2024, then slumped by 263.79% to 33025000.0 in 2025, then slipped by 1.69% to 33582000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were 33582000.0 in Q1 2026, 33025000.0 in Q4 2025, and 8588000.0 in Q3 2025.